New Medical Centre Alexandria results, Q3 2024
Net profit, assets, equity and cash flow for Q3 2024, against the same period a year earlier, from the published financial statements.
Net profit14.35 millionEGP · +127.4% vs the same period a year earlier
Total assets327 millionEGP · +10.8% vs the same period a year earlier
Shareholders' equity213 millionEGP · +6.7% vs the same period a year earlier
Operating cash flow13.6 millionEGP · +786.1% vs the same period a year earlier
In short
- New Medical Centre Alexandria's net profit for Q3 2024 was about 14.35 million EGP, up +127.4% from 6.31 million EGP in Q3 2023.
- Total assets at the end of Q3 2024 were about 327 million EGP, and shareholders' equity about 213 million EGP.
- Operating cash flow for Q3 2024 was positive at 13.6 million EGP.
Key lines against the same period a year earlier
This periodQ3 2023Change
Net profit14.35 million6.31 million+127.4%
Gross profit40.43 million24.31 million+66.3%
Total assets327 million295 million+10.8%
Total liabilities114 million95.62 million+19.2%
Shareholders' equity213 million199 million+6.7%
Total liabilities and equity327 million295 million+10.8%
Operating cash flow13.6 million1.53 million+786.1%
Investing cash flow-12.3 million-1.31 million−835.9%
Financing cash flow———
Net change in cash1.31 million221 thousand+490.1%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
New Medical Centre Alexandria's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy